Albrecht I et al.Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies.J Clin Invest 125:4612-24 (2015).
PubMed: 26551678
Feeney SJ et al.FHL1 reduces dystrophy in transgenic mice overexpressing FSHD muscular dystrophy region gene 1 (FRG1).PLoS One 10:e0117665 (2015).
WB
.
PubMed: 25695429
Sabatelli P et al.Aggresome-Autophagy Involvement in a Sarcopenic Patient with Rigid Spine Syndrome and a p.C150R Mutation in FHL1 Gene.Front Aging Neurosci 6:215 (2014).
WB
.
PubMed: 25191266
D'Arcy C et al.X-linked Recessive Distal Myopathy With Hypertrophic Cardiomyopathy Caused by a Novel Mutation in the FHL1 Gene.J Child Neurol N/A:N/A (2014).
IHC-Fr
;
Human
.
PubMed: 25246303
D'Arcy CE et al.Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.Hum Mol Genet N/A:N/A (2013).
PubMed: 24087791
Wu MP et al.G-protein coupled receptor 56 promotes myoblast fusion through serum response factor- and nuclear factor of activated T-cell-mediated signalling but is not essential for muscle development in vivo.FEBS J 280:6097-113 (2013).
PubMed: 24102982
Veith C et al.Paxillin regulates pulmonary arterial smooth muscle cell function in pulmonary hypertension.Am J Pathol 181:1621-33 (2012).
IP, ICC/IF
.
PubMed: 22959909
Isumi Y et al.Transgenic overexpression of USP15 in the heart induces cardiac remodeling in mice.Biochem Biophys Res Commun 405:216-21 (2011).
WB
;
Human
.
PubMed: 21219870
Schessl J et al.Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1.Brain 132:452-64 (2009).
PubMed: 19181672
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"